期刊
FRONTIERS IN CELLULAR NEUROSCIENCE
卷 16, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2022.868323
关键词
ischemic stroke; neuroprotection; nanoparticles; biomimetic material; blood-brain barrier
资金
- Zhejiang Provincial Natural Science Foundation of China [LGC22H180002]
- Zhejiang Medical and Health Science and Technology Project [2020KY406, 2021KY508]
- Research start-up fund of Zhejiang Provincial Peoples Hospital [ZRY2019B004]
This review focuses on the potential of nanomedicines as carriers for neuroprotective agents in the treatment of ischemic stroke. It discusses the limitations of traditional agents and the advantages of using nanoparticles. Additionally, it explores bionic delivery strategies, such as cells, cell membrane vesicles, and exosomes, which can effectively avoid clearance risks.
Ischemic stroke remains the leading cause of death and disability, while the main mechanisms of dominant neurological damage in stroke contain excitotoxicity, oxidative stress, and inflammation. The clinical application of many neuroprotective agents is limited mainly due to their inability to cross the blood-brain barrier (BBB), short half-life and low bioavailability. These disadvantages can be better eliminated/reduced by nanoparticle as the carrier of these drugs. This review expounded the currently hot researched nanomedicines from the perspective of the mechanism of ischemic stroke. In addition, this review describes the bionic nanomedicine delivery strategies containing cells, cell membrane vesicles and exosomes that can effectively avoid the risk of clearance by the reticuloendothelial system. The potential challenges and application prospect for clinical translation of these delivery platforms were also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据